Thoma Bravo buys Greenphire from Riverside

Jim Murphy, CEO of Greenphire, will continue to lead the clinical trial payments company along with the existing management team.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this